v3.22.2.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Income Statement [Abstract]        
Revenue, net $ 9,351 $ 11,155 $ 19,728 $ 20,989
Cost of revenue (excluding amortization of $535 and $1,112 for the three months and $1,071 and $2,224 for the six months, respectively) 5,850 5,800 11,234 11,116
Gross profit 3,501 5,355 8,494 9,873
Operating expenses:        
Sales and marketing 2,774 2,776 5,190 5,128
Research and development 267 424 566 1,060
General and administrative 3,907 3,326 7,597 6,362
Transition expense 61 858 146 2,111
Gain on DiamiR transaction (235) (235)
Acquisition related amortization expense 535 1,112 1,071 2,224
Change in fair value of contingent consideration (311) (311) (57)
Total operating expenses 7,233 8,261 14,259 16,593
Operating loss (3,732) (2,906) (5,765) (6,720)
Interest accretion expense 36 (135) (85) (270)
Related party interest (163) (308)
Note payable interest (210) (390)
Other income (expense), net 35 (168) 194 (212)
Loss from continuing operations before tax (3,871) (3,372) (6,046) (7,510)
Provision for income taxes 16 16 34 31
Loss from continuing operations (3,887) (3,388) (6,080) (7,541)
Loss from discontinued operations, net of tax (52) (58) (106) (112)
Net loss $ (3,939) $ (3,446) $ (6,186) $ (7,653)
Basic and diluted loss per share of common stock:        
From continuing operations $ (0.92) $ (0.83) $ (1.44) $ (1.84)
From discontinued operations (0.01) (0.01) (0.03) (0.03)
Net loss per basic and diluted share of common stock $ (0.93) $ (0.84) $ (1.47) $ (1.87)
Weighted average number of common shares and common share equivalents outstanding:        
Basic 4,229 4,102 4,219 4,095
Diluted 4,229 4,102 4,219 4,095

Source